Blockchain Registration Transaction Record

AML Therapeutics Market to Triple to $10.1B by 2036

Global AML therapeutics market to grow from $3.8B in 2025 to $10.1B by 2036 at 9.2% CAGR. Targeted therapies lead with 36% share. Key players: AbbVie, Roche, Astellas. India fastest-growing at 11.8% CAGR.

This news matters because AML is a devastating blood cancer with historically limited treatment options. The projected market growth reflects a paradigm shift toward precision medicine, offering new hope for patients through targeted therapies that are more effective and less toxic. For healthcare providers and investors, this underscores the urgent need to adopt molecular diagnostics and personalized treatment pathways. Patients stand to benefit from improved survival rates and quality of life, especially those with relapsed or refractory disease who previously had few alternatives. The rapid growth in emerging markets like India and China also signals expanding global access to advanced cancer care.